Literature DB >> 16356168

Gene expression profiling of mice with genetically modified muscle glycogen content.

Gretchen E Parker1, Bartholomew A Pederson, Mariko Obayashi, Jill M Schroeder, Robert A Harris, Peter J Roach.   

Abstract

Glycogen, a branched polymer of glucose, forms an energy re-serve in numerous organisms. In mammals, the two largest glyco-gen stores are in skeletal muscle and liver, which express tissue-specific glycogen synthase isoforms. MGSKO mice, in which mGys1 (mouse glycogen synthase) is disrupted, are devoid of muscle glycogen [Pederson, Chen, Schroeder, Shou, DePaoli-Roach and Roach (2004) Mol. Cell. Biol. 24, 7179-7187]. The GSL30 mouse line hyper-accumulates glycogen in muscle [Manchester, Skurat, Roach, Hauschka and Lawrence (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 10707-10711]. We performed a microarray analysis of mRNA from the anterior tibialis, medial gastrocnemius and liver of MGSKO mice, and from the gastroc-nemius of GSL30 mice. In MGSKO mice, transcripts of 79 genes varied in their expression in the same direction in both the anterior tibialis and gastrocnemius. These included several genes encoding proteins proximally involved in glycogen metabolism. The Ppp1r1a [protein phosphatase 1 regulatory (inhibitor) sub-unit 1A] gene underwent the greatest amount of downregulation. In muscle, the downregulation of Pfkfb1 and Pfkfb3, encoding isoforms of 6-phosphofructo-2-kinase/fructose-2,6-bisphospha-tase, is consistent with decreased glycolysis. Pathways for branched-chain amino acid, and ketone body utilization appear to be downregulated, as is the capacity to form the gluconeogenic precursors alanine, lactate and glutamine. Expression changes among several members of the Wnt signalling pathway were identified, suggesting an as yet unexplained role in glycogen meta-bolism. In liver, the upregulation of Pfkfb1 and Pfkfb3 expression is consistent with increased glycolysis, perhaps as an adaptation to altered muscle metabolism. By comparing changes in muscle expression between MGSKO and GSL30 mice, we found a subset of 44 genes, the expression of which varied as a function of muscle glycogen content. These genes are candidates for regulation by glycogen levels. Particularly interesting is the observation that 11 of these genes encode cardiac or slow-twitch isoforms of muscle contractile proteins, and are upregulated in muscle that has a greater oxidative capacity in MGSKO mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16356168      PMCID: PMC1409698          DOI: 10.1042/BJ20051456

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle.

Authors:  Z Chen; J Heierhorst; R J Mann; K I Mitchelhill; B J Michell; L A Witters; G S Lynch; B E Kemp; D Stapleton
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

2.  Control of glycogen synthesis is shared between glucose transport and glycogen synthase in skeletal muscle fibers.

Authors:  I Azpiazu; J Manchester; A V Skurat; P J Roach; J C Lawrence
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-02       Impact factor: 4.310

3.  Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis.

Authors:  Christian Meyer; Jean M Dostou; Stephen L Welle; John E Gerich
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

Review 4.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: suiting structure to need, in a family of tissue-specific enzymes.

Authors:  M R El-Maghrabi; F Noto; N Wu; N Manes
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2001-09       Impact factor: 4.294

5.  Mutations in the gal83 glycogen-binding domain activate the snf1/gal83 kinase pathway by a glycogen-independent mechanism.

Authors:  Heather A Wiatrowski; Bryce J W Van Denderen; Cristin D Berkey; Bruce E Kemp; David Stapleton; Marian Carlson
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

6.  Purification of branched chain alpha-ketoacid dehydrogenase complex from rat liver.

Authors:  Y Shimomura; R Paxton; T Ozawa; R A Harris
Journal:  Anal Biochem       Date:  1987-05-15       Impact factor: 3.365

7.  Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

Authors:  C Keller; A Steensberg; H Pilegaard; T Osada; B Saltin; B K Pedersen; P D Neufer
Journal:  FASEB J       Date:  2001-10-29       Impact factor: 5.191

8.  Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect.

Authors:  Alexander Minchenko; Irene Leshchinsky; Irina Opentanova; Nianli Sang; Vickram Srinivas; Valerie Armstead; Jaime Caro
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

Review 9.  PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.

Authors:  D A Okar; A Manzano; A Navarro-Sabatè; L Riera; R Bartrons; A J Lange
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

10.  Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.

Authors:  Patrick W B Derksen; Esther Tjin; Helen P Meijer; Melanie D Klok; Harold D MacGillavry; Marinus H J van Oers; Henk M Lokhorst; Andries C Bloem; Hans Clevers; Roel Nusse; Ronald van der Neut; Marcel Spaargaren; Steven T Pals
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

View more
  10 in total

1.  Wnt signaling regulates hepatic metabolism.

Authors:  Hongjun Liu; Maria M Fergusson; J Julie Wu; Ilsa I Rovira; Jie Liu; Oksana Gavrilova; Teng Lu; Jianjun Bao; Donghe Han; Michael N Sack; Toren Finkel
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

2.  Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice.

Authors:  Jose M Irimia; Catalina M Meyer; Caron L Peper; Lanmin Zhai; Cheryl B Bock; Stephen F Previs; Owen P McGuinness; Anna DePaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  Separating the contribution of glucocorticoids and wakefulness to the molecular and electrophysiological correlates of sleep homeostasis.

Authors:  Valérie Mongrain; Susana A Hernandez; Sylvain Pradervand; Stéphane Dorsaz; Thomas Curie; Grace Hagiwara; Phung Gip; H Craig Heller; Paul Franken
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

4.  Identification of differentially expressed genes in chickens differing in muscle glycogen content and meat quality.

Authors:  Vonick Sibut; Christelle Hennequet-Antier; Elisabeth Le Bihan-Duval; Sylvain Marthey; Michel J Duclos; Cécile Berri
Journal:  BMC Genomics       Date:  2011-02-16       Impact factor: 3.969

5.  Expression analysis of human adipose-derived stem cells during in vitro differentiation to an adipocyte lineage.

Authors:  Latha Satish; J Michael Krill-Burger; Phillip H Gallo; Shelley Des Etages; Fang Liu; Brian J Philips; Sudheer Ravuri; Kacey G Marra; William A LaFramboise; Sandeep Kathju; J Peter Rubin
Journal:  BMC Med Genomics       Date:  2015-07-24       Impact factor: 3.063

6.  Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells.

Authors:  Haymanti Bhanot; Mamatha M Reddy; Atsushi Nonami; Ellen L Weisberg; Dennis Bonal; Paul T Kirschmeier; Sabrina Salgia; Klaus Podar; Ilene Galinsky; Tirumala K Chowdary; Donna Neuberg; Giovanni Tonon; Richard M Stone; John Asara; James D Griffin; Martin Sattler
Journal:  Leukemia       Date:  2015-02-23       Impact factor: 11.528

7.  SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer.

Authors:  Y-H Taguchi; Mitsuo Iwadate; Hideaki Umeyama
Journal:  BMC Med Genomics       Date:  2016-08-12       Impact factor: 3.063

8.  Gain of function AMP-activated protein kinase γ3 mutation (AMPKγ3R200Q) in pig muscle increases glycogen storage regardless of AMPK activation.

Authors:  Tracy L Scheffler; Sungkwon Park; Peter J Roach; David E Gerrard
Journal:  Physiol Rep       Date:  2016-06

Review 9.  The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment.

Authors:  Gaelan Melanson; Sara Timpano; James Uniacke
Journal:  Oxid Med Cell Longev       Date:  2017-11-26       Impact factor: 6.543

10.  mTORC2 and AMPK differentially regulate muscle triglyceride content via Perilipin 3.

Authors:  Maximilian Kleinert; Benjamin L Parker; Rima Chaudhuri; Daniel J Fazakerley; Annette Serup; Kristen C Thomas; James R Krycer; Lykke Sylow; Andreas M Fritzen; Nolan J Hoffman; Jacob Jeppesen; Peter Schjerling; Markus A Ruegg; Bente Kiens; David E James; Erik A Richter
Journal:  Mol Metab       Date:  2016-06-22       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.